About 7 results found for searched term "Protease-Activated Receptor-4" (0.122 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M52921 | Protease-Activated Receptor-4 | PAR |
| Protease-Activated Receptor-4 is the agonist of proteinase-activated receptor-4 (PAR4). | ||
| M8538 | ML354 | PAR |
| ML354 is a potent and selective PAR4 (protease activated receptor-4) antagonist. | ||
| M9812 | PAR-4 (1-6) (human) | PAR |
| GYPGQV | ||
| PAR-4 (1-6) (human) is an N-terminal fragment of protease-activated receptor 4 (PAR4) that acts as a PAR4 agonist. | ||
| M10237 | Protease-Activated Receptor-2, amide | PAR |
| SLIGKV-NH2 | ||
| Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent agonist of PAR2 with IC50 of 10.4 uM. | ||
| M21101 | BMS-986120 | PAR |
| BMS-986120 is a first-in-class oral protease-activated receptor 4 (PAR4) inhibitor with IC50 values of 9.5 nM in human and 2.1 nM in monkey blood.BMS-986120 exhibits potent and selective antiplatelet effects. BMS-986120 has potent and selective antiplatelet effects and can be used in studies related to arterial thrombosis. | ||
| M28523 | UDM-001651 | PAR |
| UDM-001651 is a potent, selective, and orally bioavailable protease-activated receptor 4 (PAR4) antagonist (IC50=4 nM; Kd=1.4 nM). UDM-001651 shows antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay (γ-Thr PRP). | ||
| M54324 | PAR-4 (1-6) amide (human) | Others |
| PAR-4 (1-6) amide human is an N-terminal fragment of protease-activated receptor 4 (PAR4). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
